Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis
Year of publication: |
2011
|
---|---|
Authors: | Hoyle, Martin |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 29.2011, 1, p. 1-15
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Cost-effectiveness | Discount-rate | Drug-cost |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
Bos, J.M., (2005)
-
Polinder, Suzanne, (2005)
-
Common Drug Review Recommendations: An Evidence Base for Expectations?
Rocchi, Angela, (2012)
- More ...
-
Future Drug Prices and Cost-Effectiveness Analyses
Hoyle, Martin, (2008)
-
Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis
Hoyle, Martin, (2011)
-
Future Drug Prices and Cost-Effectiveness Analyses
Hoyle, Martin, (2008)
- More ...